Drug Screening Industry Overview
The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
The growth of this market is driven by increasing drug and alcohol consumption, stricter laws mandating drug and alcohol testing, and increasing regulatory approvals for drug screening products and services.
COVID-19 impact on the drug screening market
COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.
Drug Screening Market Segmentation
Services segment is expected to grow at the highest CAGR during the forecast period.
Based on service and product, the drug screening market is segmented into services and products. The services segment accounted for the largest share of 57.4% of the drug screening market
Analytical instruments are expected to dominate the drug screening products market.
Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. the analytical segment is expected to dominate the market with a share of 53.0%.
Based on the sample type, the urine sample segment is accounted for the largest share of the drug screening market.
By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these, the urine sample segment is expected to account for the largest share of 61.5%.
Drug Screening Regional Outlook
- North America
- Europe
- Asia Pacific
- RoAPAC
- Rest of the World
- Latin America
- Middle East & Africa
Key Companies Profile & Market Share Insights
The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan).
LabCorp (US): LabCorp is a leading player in the US drug screening services market. The company’s leading position is attributed to its wide drug testing portfolio, including over 4,800 tests.
Request for Sample Page: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
